CNS pipeline · person
Suzanne Bruhn, PhD
Independent Board Director of Definium Therapeutics since August 2022 (Chair of the Compensation Committee). A life sciences executive; currently President and CEO of Tiaki Therapeutics, previously President and CEO of Proclara Biosciences and Promedior, with 13 years at Shire Human Genetic Therapies. PhD in chemistry from MIT.
- 1 company
Courtesy Definium Therapeutics
Current roles
- Definium Therapeutics, Inc.Board Director · Board
Appears with
People sharing a company with Suzanne.
- Andreas Krebs · Definium Therapeutics, Inc.
- Brandi Roberts · Definium Therapeutics, Inc.
- Carol A. Vallone · Definium Therapeutics, Inc.
- Daniel R. Karlin · Definium Therapeutics, Inc.
- Gregg Pratt · Definium Therapeutics, Inc.
- Mark Sullivan · Definium Therapeutics, Inc.
- Matt Wiley · Definium Therapeutics, Inc.
- Maurizio Fava · Definium Therapeutics, Inc.
- Robert Barrow · Definium Therapeutics, Inc.
- Robert C. Malenka · Definium Therapeutics, Inc.
- Roger Adsett · Definium Therapeutics, Inc.
- Stephanie Fagan · Definium Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.